The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 114 results:
Author Title Type [ Year(Asc)]
Filters: Author is Doumas, Michael  [Clear All Filters]
2017
Doumas, M., Tsioufis C., Fletcher R., Amdur R., Faselis C., & Papademetriou V. (2017).  Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension.. J Am Heart Assoc. 6(11), 
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
2016
Boutari, C., Stavropoulos K., Imprialos K. P., Petidis K., & Doumas M. (2016).  Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?. Am J Hypertens. 29(5), 662.
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., Athyros V. G., & Karagiannis A. I. (2016).  Current challenges in antihypertensive treatment in the elderly.. Pol Arch Med Wewn. 126(7-8), 540-51.
Imprialos, K., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2016).  Depression in hypertensive patients: the role of comorbidities.. J Hypertens. 34(7), 1441.
Athyros, V. Gabriel, Doumas M., & Karagiannis A. (2016).  Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action.. Indian Heart J. 68(5), 596-598.
Imprialos, K., Boutari C., & Doumas M. (2016).  Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function.. JAMA Intern Med. 176(3), 409.
Stergiou, G. S., Doumas M., Kollias A., & Papademetriou V. (2016).  Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed.. J Am Soc Hypertens. 10(8), 613-7.
Katsiki, N., Doumas M., & Mikhailidis D. P. (2016).  Lipids, Statins and Heart Failure: An Update.. Curr Pharm Des. 22(31), 4796-4806.
Papademetriou, V., Doumas M., & Tsioufis C. (2016).  Renal Sympathetic Denervation: Hibernation or Resurrection?. Cardiology. 135(2), 87-97.
2015
Doumas, M., Papademetriou V., Athyros V., & Karagiannis A. (2015).  Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.. Angiology. 66(10), 901-3.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Papadopoulou, E., Varouktsi A., Lazaridis A., Boutari C., & Doumas M. (2015).  Erectile dysfunction in chronic kidney disease: From pathophysiology to management.. World J Nephrol. 4(3), 379-87.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2015).  Hyperuricemia as a risk factor for cardiovascular disease.. Expert Rev Cardiovasc Ther. 13(1), 19-20.
Kargiotis, K., Athyros V. G., Giouleme O., Katsiki N., Katsiki E., Anagnostis P., et al. (2015).  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.. World J Gastroenterol. 21(25), 7860-8.
Doumas, M., Athyros V., & Papademetriou V. (2015).  Screening for Primary Aldosteronism: Whom and How?. J Clin Hypertens (Greenwich). 17(7), 547-8.
Doumas, M., Athyros V., & Karagiannis A. (2015).  Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?. Cardiology. 131(3), 186-8.
2014
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Antihypertensive therapy after acute ischemic stroke.. JAMA. 311(22), 2333-4.
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Combined angiotensin inhibition in diabetic nephropathy.. N Engl J Med. 370(8), 778-9.
Doumas, M. (2014).  Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?. Curr Vasc Pharmacol. 12(1), 2-3.
Reklou, A., Lazaridis A., Nikolaidou B., Kadiltzoglou P., & Doumas M. (2014).  Macro and microcirculation damage and incident hypertension: predictors of progression?. J Hypertens. 32(5), 1154.
Doumas, M., Tsioufis C., Faselis C., Lazaridis A., Grassos H., & Papademetriou V. (2014).  Non-interventional management of resistant hypertension.. World J Cardiol. 6(10), 1080-90.
Gkaliagkousi, E., Gavriilaki E., Yiannaki E., Markala D., Papadopoulos N., Triantafyllou A., et al. (2014).  Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker.. Am J Hypertens. 27(4), 571-8.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2014).  Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit.. Expert Rev Cardiovasc Ther. 12(3), 295-6.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.